ARCC: Ares Capital Corporation Stock

SIC 6798 – Real Estate Investment Trusts

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 13,355.00
Book Value / Share n/a
Price / Book n/a
NCAV ($M) -13,523.00
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.13

Liquidity (mrq)
Quick Ratio 0.50
Current Ratio 0.50

Balance Sheet (mrq) ($M)
Current Assets 1,376.00
Assets 28,254.00
Liabilities 14,899.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,990.00
Operating Income 2,191.00
Net Income 1,522.00

Cash Flow Statement (mra) ($M)
Cash From Operations -2,128.00
Cash from Investing 0.00
Cash from Financing 2,424.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION R
2025-02-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SE
2024-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPORT PURSUANT
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PURSUANT TO S
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 o TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 1,207,663 7,039,430 17.16
2025-04-10 1,770,771 6,697,753 26.44
2025-04-09 2,687,814 14,317,848 18.77
2025-04-08 2,364,710 10,450,605 22.63

(click for more detail)

Similar Companies
ACTG – Acacia Research Corporation AGNC – AGNC Investment Corp.
DHC – Diversified Healthcare Trust EQIX – Equinix, Inc.


Financial data and stock pages provided by
Fintel.io